Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study (Q82837028)
Jump to navigation
Jump to search
scientific article published on 06 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study |
scientific article published on 06 December 2011 |
Statements
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled phase 2 dose-ranging study (English)
Asit Parikh
Timothy Leach
Tim Wyant
Catherine Scholz
Serap Sankoh
Diane R Mould
Terry Ponich
Irving Fox